Mufg Securities Americas Inc. Purchases Shares of 1,778 Humana Inc. (NYSE:HUM)

Mufg Securities Americas Inc. purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,778 shares of the insurance provider’s stock, valued at approximately $451,000.

Other hedge funds have also modified their holdings of the company. Transcend Capital Advisors LLC lifted its position in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. Retirement Systems of Alabama increased its holdings in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after acquiring an additional 65,735 shares in the last quarter. Secure Asset Management LLC acquired a new position in shares of Humana during the fourth quarter valued at about $244,000. Finally, denkapparat Operations GmbH acquired a new position in shares of Humana during the fourth quarter valued at about $323,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Down 1.8%

Shares of NYSE:HUM opened at $226.26 on Friday. The business has a 50-day moving average price of $263.20 and a 200 day moving average price of $269.61. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $27.31 billion, a price-to-earnings ratio of 22.74, a PEG ratio of 2.05 and a beta of 0.49. Humana Inc. has a 12-month low of $212.45 and a 12-month high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the company earned $7.23 EPS. Sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.56%. Humana’s dividend payout ratio (DPR) is presently 25.04%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on HUM. Raymond James upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price objective on the stock in a report on Thursday, May 1st. Mizuho upped their price objective on shares of Humana from $305.00 to $316.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Guggenheim began coverage on shares of Humana in a report on Wednesday, April 9th. They set a “buy” rating and a $326.00 price objective on the stock. JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Finally, Oppenheimer upped their price objective on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a report on Thursday, May 1st. Seventeen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $286.81.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.